pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1268a |
Genomic Coordinates | chr15: 22225278 - 22225329 |
Description | Homo sapiens miR-1268a stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1268a | ||||||||||||||||||||||||||||||||||||
Sequence | 5| CGGGCGUGGUGGUGGGGG |22 | ||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FASN | ||||||||||||||||||||
Synonyms | FAS, OA-519, SDR27X1 | ||||||||||||||||||||
Description | fatty acid synthase | ||||||||||||||||||||
Transcript | NM_004104 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FASN | |||||||||||||||||||||
3'UTR of FASN (miRNA target sites are highlighted) |
>FASN|NM_004104|3'UTR 1 GCCCGTGCCCCCGCCTGCCACCGGAGGTCACTCCACCATCCCCACCCCACCCCACCCCACCCCCGCCATGCAACGGGATT 81 GAAGGGTCCTGCCGGTGGGACCCTGTCCGGCCCAGTGCCACTGCCCCCCGAGGCTGCTAGATGTAGGTGTTAGGCATGTC 161 CCACCCACCCGCCGCCTCCCACGGCACCTCGGGGACACCAGAGCTGCCGACTTGGAGACTCCTGGTCTGTGAAGAGCCGG 241 TGGTGCCCGTGCCCGCAGGAACTGGGCTGGGCCTCGTGCGCCCGTGGGGTCTGCGCTTGGTCTTTCTGTGCTTGGATTTG 321 CATATTTATTGCATTGCTGGTAGAGACCCCCAGGCCTGTCCACCCTGCCAAGACTCCTCAGGCAGCGTGTGGGTCCCGCA 401 CTCTGCCCCCATTTCCCCGATGTCCCCTGCGGGCGCGGGCAGCCACCCAAGCCTGCTGGCTGCGGCCCCCTCTCGGCCAG 481 GCATTGGCTCAGCCCGCTGAGTGGGGGGTCGTGGGCCAGTCCCCGAGGAGCTGGGCCCCTGCACAGGCACACAGGGCCCG 561 GCCACACCCAGCGGCCCCCCGCACAGCCACCCGTGGGGTGCTGCCCTTATGCCCGGCGCCGGGCACCAACTCCATGTTTG 641 GTGTTTGTCTGTGTTTGTTTTTCAAGAAATGATTCAAATTGCTGCTTGGATTTTGAAATTTACTGTAACTGTCAGTGTAC 721 ACGTCTGGACCCCGTTTCATTTTTACACCAATTTGGTAAAAATGCTGCTCTCAGCCTCCCACAATTAAACCGCATGTGAT 801 CTCCAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Flp-In T-REx 293-hAGO1 cells | ||||||
Location of target site | CDS | ||||||
Original Description (Extracted from the article) |
...
Validation of interactions identified by CLASH suppports their reliability.
... - Helwak A; Kudla G; Dudnakova T; Tollervey D, 2013, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Helwak A; Kudla G; Dudnakova T; Tollervey D - Cell, 2013
MicroRNAs (miRNAs) play key roles in gene regulation, but reliable bioinformatic or experimental identification of their targets remains difficult. To provide an unbiased view of human miRNA targets, we developed a technique for ligation and sequencing of miRNA-target RNA duplexes associated with human AGO1. Here, we report data sets of more than 18,000 high-confidence miRNA-mRNA interactions. The binding of most miRNAs includes the 5' seed region, but around 60% of seed interactions are noncanonical, containing bulged or mismatched nucleotides. Moreover, seed interactions are generally accompanied by specific, nonseed base pairing. 18% of miRNA-mRNA interactions involve the miRNA 3' end, with little evidence for 5' contacts, and some of these were functionally validated. Analyses of miRNA:mRNA base pairing showed that miRNA species systematically differ in their target RNA interactions, and strongly overrepresented motifs were found in the interaction sites of several miRNAs. We speculate that these affect the response of RISC to miRNA-target binding.
LinkOut: [PMID: 23622248]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
44 hsa-miR-1268a Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT035845 | POLR2I | RNA polymerase II subunit I | 1 | 1 | ||||||||
MIRT035847 | FASN | fatty acid synthase | 1 | 1 | ||||||||
MIRT053736 | SOX12 | SRY-box 12 | 1 | 1 | ||||||||
MIRT053737 | CAMK2G | calcium/calmodulin dependent protein kinase II gamma | 1 | 1 | ||||||||
MIRT473717 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 2 | ||||||||
MIRT483654 | QSOX2 | quiescin sulfhydryl oxidase 2 | 2 | 4 | ||||||||
MIRT484277 | AIP | aryl hydrocarbon receptor interacting protein | 2 | 4 | ||||||||
MIRT486674 | WDR81 | WD repeat domain 81 | 2 | 2 | ||||||||
MIRT488672 | WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 2 | 4 | ||||||||
MIRT493453 | ITFG3 | family with sequence similarity 234 member A | 2 | 2 | ||||||||
MIRT495902 | ZNF641 | zinc finger protein 641 | 2 | 2 | ||||||||
MIRT500188 | BARX1 | BARX homeobox 1 | 2 | 4 | ||||||||
MIRT512015 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 2 | ||||||||
MIRT521134 | SGPL1 | sphingosine-1-phosphate lyase 1 | 2 | 4 | ||||||||
MIRT530047 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT531519 | NOM1 | nucleolar protein with MIF4G domain 1 | 2 | 2 | ||||||||
MIRT543736 | DHCR7 | 7-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT558054 | EVI5L | ecotropic viral integration site 5 like | 2 | 2 | ||||||||
MIRT569603 | TRIM29 | tripartite motif containing 29 | 2 | 2 | ||||||||
MIRT570027 | FAM228A | family with sequence similarity 228 member A | 2 | 2 | ||||||||
MIRT573595 | CERS1 | ceramide synthase 1 | 2 | 2 | ||||||||
MIRT623884 | FRMPD4 | FERM and PDZ domain containing 4 | 2 | 2 | ||||||||
MIRT630000 | PDE6B | phosphodiesterase 6B | 2 | 2 | ||||||||
MIRT632716 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 2 | 2 | ||||||||
MIRT633497 | ERO1L | endoplasmic reticulum oxidoreductase 1 alpha | 1 | 1 | ||||||||
MIRT637076 | SELPLG | selectin P ligand | 2 | 2 | ||||||||
MIRT638183 | TLN1 | talin 1 | 2 | 2 | ||||||||
MIRT638767 | EPB41 | erythrocyte membrane protein band 4.1 | 2 | 2 | ||||||||
MIRT668073 | GMPS | guanine monophosphate synthase | 2 | 2 | ||||||||
MIRT669874 | RAET1E | retinoic acid early transcript 1E | 2 | 2 | ||||||||
MIRT670664 | KIAA1551 | KIAA1551 | 2 | 2 | ||||||||
MIRT671283 | RPL37A | ribosomal protein L37a | 2 | 2 | ||||||||
MIRT675055 | OR7D2 | olfactory receptor family 7 subfamily D member 2 | 2 | 2 | ||||||||
MIRT682784 | BLOC1S3 | biogenesis of lysosomal organelles complex 1 subunit 3 | 2 | 2 | ||||||||
MIRT683344 | SCARF1 | scavenger receptor class F member 1 | 2 | 2 | ||||||||
MIRT690283 | ZNF154 | zinc finger protein 154 | 2 | 2 | ||||||||
MIRT695172 | SLC25A33 | solute carrier family 25 member 33 | 2 | 2 | ||||||||
MIRT695222 | SCAMP3 | secretory carrier membrane protein 3 | 2 | 2 | ||||||||
MIRT700485 | PTPRF | protein tyrosine phosphatase, receptor type F | 2 | 2 | ||||||||
MIRT700601 | PRKCA | protein kinase C alpha | 2 | 2 | ||||||||
MIRT701410 | NKRF | NFKB repressing factor | 2 | 2 | ||||||||
MIRT703995 | EIF5A2 | eukaryotic translation initiation factor 5A2 | 2 | 2 | ||||||||
MIRT711232 | RETSAT | retinol saturase | 2 | 2 | ||||||||
MIRT719510 | TMEM175 | transmembrane protein 175 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|